● Recruiting

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

Condition: Locally Advanced or Metastatic Solid Tumors · Colorectal Cancer · Gastric Cancer · Sponsor: ArriVent BioPharma, Inc.

PhasePhase 1

Planned participants572

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is an open-label, multi-center, phase I study to evaluate the safety, tolerability, efficacy, and pharmacokinetics of MRG007 (ARR-217) in patients with unresectable locally advanced or metastatic solid tumors.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Trials · (888) 622-2827 · ClinicalTrials.gov@ArriVent.com

Always discuss trial participation with your own doctor first.

Locations (21)

ULCA	Los Angeles, California, United States	Recruiting
UCSF	San Francisco, California, United States	Recruiting
University of Colorado	Aurora, Colorado, United States	Recruiting
Sarah Cannon Research Institute	Denver, Colorado, United States	Recruiting
Sarah Cannon Research Institute	Sarasota, Florida, United States	Recruiting
Sarah Cannon Research Institute	Nashville, Tennessee, United States	Recruiting
MD Anderson Cancer Center	Houston, Texas, United States	Recruiting
NEXT Dallas	Irving, Texas, United States	Recruiting
NEXT Virginia	Fairfax, Virginia, United States	Recruiting
Fred Hutchinson Cancer Center	Seattle, Washington, United States	Recruiting
Peking University Cancer Hospital	Beijing, Beijing Municipality, China	Recruiting
Beijing Gobroad Hospital	Beijing, Beijing Municipality, China	Recruiting

+ 9 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07066657